PD-L1, LAG-3, and GAL-3 Expression in Anal Squamous Cell Carcinoma

被引：0
|
作者：
Ju, Jennifer [1 ]
Mills, Anne [2 ]
Stelow, Edward [1 ]
机构：
[1] Univ Virginia Hlth Syst, Charlottesville, VA USA
[2] Univ Virginia, Charlottesville, VA USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
660
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clinical Significance and Prognostic Value of the Expression of LAG-3 and FGL1 in Esophageal Squamous Cell Carcinoma
    X. M. Yao
    F. H. Zhang
    Y. Liu
    Bulletin of Experimental Biology and Medicine, 2023, 174 : 774 - 778
  • [42] HBD3 Induces PD-L1 Expression on Head and Neck Squamous Cell Carcinoma Cell Lines
    Hernandez, Maria Paula Gomez
    Bates, Amber M.
    Starman, Emily E.
    Lanzel, Emily A.
    Comnick, Carissa
    Xie, Xian Jin
    Brogden, Kim A.
    ANTIBIOTICS-BASEL, 2019, 8 (04):
  • [43] Clinical Significance and Prognostic Value of the Expression of LAG-3 and FGL1 in Esophageal Squamous Cell Carcinoma
    Yao, X. M.
    Zhang, F. H.
    Liu, Y.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 174 (06) : 774 - 778
  • [44] Immunotherapeutic strategies beyond the PD-1/PD-L1 pathway in head and neck squamous cell carcinoma - A scoping review on current developments in agents targeting TIM-3, TIGIT, LAG-3, and VISTA
    Struckmeier, Ann-Kristin
    Gosau, Martin
    Smeets, Ralf
    ORAL ONCOLOGY, 2025, 161
  • [45] A PHASE II STUDY OF EFTILAGIMOD ALPHA (SOLUBLE LAG-3 PROTEIN) AND PEMBROLIZUMAB IN PATIENTS UNSELECTED FOR PD-L1 EXPRESSION IN FIRST LINE METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)
    Peguero, Julio
    Triebel, Frederic
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A470 - A470
  • [46] PD-L1 (22C3) expression and prognostic implications in esophageal squamous cell carcinoma
    Chi, Zhikai
    Peng, Lan
    Karamchandani, Dipti M.
    Xu, Jing
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2025, 74
  • [47] Prognostic Value of Lymphocyte Activation Gene-3 (LAG-3) Expression in Esophageal Squamous Cell Carcinoma
    Zhang, Yu
    Liu, Yong-dong
    Luo, Yi-ling
    Liu, Bin-liu
    Huang, Qi-tao
    Wang, Fang
    Zhong, Qian
    JOURNAL OF CANCER, 2018, 9 (22): : 4287 - 4293
  • [48] The tetravalent structure of FS118, a bispecific antibody targeting LAG-3 and PD-L1, is required for its novel mechanism of LAG-3 shedding
    Reader, Claire S.
    Liao, Wenjia
    Potter-Landau, Beatrice J.
    Veyssier, Christel Seguy
    Rhoades, Martyn C.
    Seal, Claire J.
    Morrow, Michelle
    Brewis, Neil
    CANCER RESEARCH, 2022, 82 (12)
  • [49] PD-L1 in oral squamous cell carcinoma
    Ragos, Vasileios
    Mastronikolis, Nicholas S.
    Tsiambas, Evangelos
    Fotiades, Panagiotis P.
    JOURNAL OF BUON, 2018, 23 (03): : 835 - 836
  • [50] PD-L1 expression in pancreatic adenosquamous carcinoma: PD-L1 expression is limited to the squamous component
    Tanigawa, Masahiko
    Naito, Yoshiki
    Akiba, Jun
    Kawahara, Akihiko
    Okabe, Yoshinobu
    Ishida, Yusuke
    Ishikawa, Hiroto
    Hisaka, Toru
    Fujita, Fumihiko
    Yasunaga, Masafumi
    Shigaki, Takahiro
    Sudo, Tomoya
    Mihara, Yutaro
    Nakayama, Masamichi
    Kondo, Reiichiro
    Kusano, Hironori
    Shimamatsu, Kazuhide
    Okuda, Koji
    Akagi, Yoshito
    Yano, Hirohisa
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (12) : 2069 - 2074
12345